University of Western Australia at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
University of Western Australia brings 2 presentations to IDWeek 2026 in Washington. Its program centres on how pediatric infectious disease practice compares across continents. It covers using trimethoprim-sulfamethoxazole to treat staphylococcal and streptococcal infections.
| Organization | IDWeek 2026 Attendance |
|---|---|
University of Western Australia Perth, Australia | |
Session Sat Oct 24 8:00am–9:00am Connecting Continents: Shared Challenges and Contrasting Customs in Peds ID Global and public health Talk Sat Oct 24 8:30am–9:00am Use of Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) for Staphylococcal and Streptococcal Infection Global and public healthAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from University of Western Australia
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction